News Coverage 03.10.20 Share on Twitter Share on Facebook Share on LinkedIn CRISPR-edited immune cells can survive and thrive after infusion into cancer patients Related Announcement, From Bench to Fireside PICI’s From Bench to Fireside Podcast Returns Announcement PICI 2024: Collaborative Breakthroughs in Cancer Immunotherapy Announcement, Press Release Parker Institute Awards $525,000 to Advance Diverse Talent in Cancer Research
Announcement, Press Release Parker Institute Awards $525,000 to Advance Diverse Talent in Cancer Research